Skip to market wire
InvestLog
← Back to Stock Events← 返回个股快讯
PFESEC Material DisclosureSEC 重大披露SEC sourceSEC 来源Source link原始来源by InvestLog AIInvestLog AI 整理
Event time: 事件时间：
Published: 文章发布：

PFIZER INC files 8-K Item 5.02 executive-change disclosure辉瑞 (PFE) 提交 8-K Item 5.02 高管变动披露

PFIZER INC files 8-K Item 5.02 executive-change disclosure. The SEC accepted the filing at 2026-11-03T16:19:24-05:00; filing excerpt: (the “Company”) announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026 (the “Effective Date”)..

Source: SEC filing

辉瑞 (PFE) 提交 8-K Item 5.02 高管变动披露。SEC 接收时间为 2026-11-03T16:19:24-05:00；文件摘要：(the “Company”) announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026 (the “Effective Date”).。

来源：SEC 原始文件

View PFE stock details ->查看 PFE 个股详情 ->

For information only. Not investment advice.内容仅供参考，不构成投资建议。

Related articles相关阅读

PFE earnings release — EPS beat +18.4% · revenue beat +4.6%辉瑞 (PFE) 财报发布 — EPS 高于预期+18.4% · 营收 高于预期+4.6%

Earnings Release · November 3, 2026财报快讯 · 2026/11/3

PFE executive change: Pfizer Appoints Cecile Guegan as Chief Financial OfficerPfizer Inc.（PFE）披露高管变动：任命 Cecile Guegan 为首席财务官

Material Company Event · November 3, 2026公司公告 · 2026/11/3

Cantor Fitzgerald raises PFE target to $28Cantor Fitzgerald 上调目标价 辉瑞 (PFE) 至 $28

Rating Change · October 8, 2026评级变动 · 2026/10/8